Education
About Us
Working with TipRanks
Follow Us
Protara Therapeutics (TARA)
NASDAQ:TARA
Protara Therapeutics (TARA) Ownership Overview
9.56% Insiders
4.24% Mutual Funds
54.89% Other Institutional Investors
3.84% ETFs
27.47% Public Companies and
Individual Investors
The ownership structure of Protara Therapeutics (TARA) stock is a mix of institutional, retail, and individual investors. Approximately 62.97% of the company’s stock is owned by Institutional Investors, 9.56% is owned by Insiders, and 27.47% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 12, 2024 | Opaleye Management Inc. >10% Owner | xxxxxxxxxxxxx | $270458 |
| Sep 10, 2024 | Opaleye Management Inc. >10% Owner | xxxxxxxxxxxxx | $113850 |
| Jul 18, 2024 | Opaleye Management Inc. >10% Owner | xxxxxxxxxxxxx | $27806 |
| Jul 11, 2024 | Opaleye Management Inc. >10% Owner | xxxxxxxxxxxxx | $175502 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $105600 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $2730562 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $4504684 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $8870400 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,400,000 | Institution | 9.25% | 15,028,000 | |
| 1,989,134 | Insider | 5.41% | 8,791,972 | |
| 1,680,000 | Institution | 4.57% | 7,425,600 | |
| 1,319,896 | Institution | 3.59% | 5,833,940 | |
| 1,319,896 | Institution | 3.59% | 5,833,940 | |
| 994,022 | Insider | 2.70% | 4,393,577 | |
| 853,160 | Institution | 2.32% | 3,770,967 | |
| 536,832 | Institution | 1.46% | 2,372,797 | |
| 517,152 | Institution | 1.41% | 2,285,812 | |
| 198,000 | Insider | 0.54% | 875,160 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,319,896 | Institution | 3.59% | 5,833,940 | |
| 158,890 | Institution | 0.43% | 702,294 | |
| 25,000 | Institution | 0.07% | 110,500 | |
| 20,334 | Institution | 0.06% | 89,876 | |
| 19,042 | Institution | 0.05% | 84,166 | |
| 16,636 | Institution | 0.05% | 73,531 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,023,901 | Institution | 2.78% | 3,829,390 | |
| 295,995 | Institution | 0.81% | 1,107,021 | |
| 40,384 | Institution | 0.11% | 178,497 | |
| 28,760 | Institution | 0.08% | 123,956 | |
| 5,784 | Institution | 0.02% | 24,929 | |
| 4,589 | Institution | 0.01% | 19,779 | |
| 4,453 | Institution | 0.01% | 19,192 | |
| 3,236 | Institution | <0.01% | 13,947 | |
| 2,484 | Institution | <0.01% | 10,706 | |
| 2,430 | Institution | <0.01% | 10,473 |
FAQ
Who Owns Protara Therapeutics (TARA)?
According to the latest TipRanks data, approximately 54.89% of the company's stock is held by institutional investors, 9.56% is held by insiders, and 27.47% is held by retail investors.
What percentage of Protara Therapeutics (TARA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 54.89% of Protara Therapeutics (TARA) stock is held by institutional investors.
What percentage of Protara Therapeutics (TARA) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.47% of Protara Therapeutics (TARA) stock is held by retail investors.
Who owns the most shares of Protara Therapeutics (TARA)?
Peter Kolchinsky owns the most shares of Protara Therapeutics (TARA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.